European Stem Cell Patent Ban Good?

Following last week’s ruling by the European Court of Justice that research procedures involving human embryonic stem cells cannot be patented, European researchers, lawyers, and investors are striving to put a positive spin on the decision. 

By | October 24, 2011

Embryo manipulation equipmentWELLCOME IMAGES, ALAN HANDYSIDE

Following last week’s ruling by the European Court of Justice that research procedures involving human embryonic stem cells cannot be patented, European researchers, lawyers, and investors are striving to put a positive spin on the decision. "If anything the ruling is an opportunity," biochemical engineer Chris Mason of University College London told Nature. "It's not the end of stem cells in Europe."

Although the cells themselves are out of bounds, companies will still be able to patent affiliated technologies, such as the equipment, growth media, and chemicals, used to develop treatments from embryonic stem cells. The ruling may even help attract more scientists to Europe, according to Nature, since they won’t have to worry about infringing on existing patents.

Add a Comment

Avatar of: You

You

Processing...
Processing...

Sign In with your LabX Media Group Passport to leave a comment

Not a member? Register Now!

LabX Media Group Passport Logo

Comments

Avatar of: Qlidnaque

Qlidnaque

Posts: 1

October 26, 2011

hopefully something good comes out of this bad. better yet, the ruling is overturned again in within the next year.

Avatar of:

Posts: 0

October 26, 2011

hopefully something good comes out of this bad. better yet, the ruling is overturned again in within the next year.

Avatar of:

Posts: 0

October 26, 2011

hopefully something good comes out of this bad. better yet, the ruling is overturned again in within the next year.

Popular Now

  1. Broad Wins CRISPR Patent Interference Case
    Daily News Broad Wins CRISPR Patent Interference Case

    The USPTO’s Patent Trial and Appeal Board has ruled in favor of the Broad Institute of MIT and Harvard retaining intellectual property rights covered by its patents for CRISPR gene-editing technology.

  2. Henrietta Lacks’s Family Seeks Compensation
  3. Humans Never Stopped Evolving
    Features Humans Never Stopped Evolving

    The emergence of blood abnormalities, an adult ability to digest milk, and changes in our physical appearance point to the continued evolution of the human race.

  4. Abundant Sequence Errors in Public Databases
Business Birmingham